Johnson & Johnson launched a new largescale latestage trial on Monday to test a twodose regimen of its experimental COVID19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: